RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NBTX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Nanobiotix S.A. stock price up 2.96% on Wednesday
(Updated on Jul 03, 2024)

Sell candidate since Jun 04, 2024 Loss -18.26% PDF

The Nanobiotix S.A. stock price gained 2.96% on the last trading day (Wednesday, 3rd Jul 2024), rising from $5.24 to $5.40. During the last trading day the stock fluctuated 3.95% from a day low at $5.31 to a day high of $5.52. The price has risen in 6 of the last 10 days and is up by 18.83% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 thousand more shares were traded than the day before. In total, 3 thousand shares were bought and sold for approximately $17.26 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.42% during the next 3 months and, with a 90% probability hold a price between $3.53 and $5.95 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NBTX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Nanobiotix S.A. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Nanobiotix S.A. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.93. On a fall, the stock will find some support from the short-term average at $5.27. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, June 27, 2024, and so far it has fallen -3.66%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Nanobiotix S.A. stock

Nanobiotix S.A. finds support from accumulated volume at $5.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.210 between high and low, or 3.95%. For the last week, the stock has had daily average volatility of 5.56%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NBTX) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Nanobiotix S.A. to open at $5.41, and during the day (based on 14 day Average True Range), to move between $5.03 and $5.76, which gives a possible trading interval of +/-$0.370 (+/-6.85%) up or down from last closing price. If Nanobiotix S.A. takes out the full calculated possible swing range there will be an estimated 13.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.38 (0.28%) than the resistance at $5.50 (1.95%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Nanobiotix S.A. stock A Buy?

Nanobiotix S.A. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.250 Sell Candidate Unchanged

Predicted Opening Price for Nanobiotix S.A. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$5.41 ( 0.247%) $5.40

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NBTX

Fibonacci Support & Resistance Levels

Level Price
R3 5.62 4.14%
R2 5.54 2.65%
R1 5.49 1.73%
Price 5.40
S1 5.33 -1.24%
S2 5.28 -2.16%
S3 5.20 -3.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.71 5.84%
R2 5.59 3.61%
R1 5.50 1.95%
Price 5.40
S1 5.38 -0.278%
S2 4.88 -9.55%
S3 4.60 -14.74%

FAQ

What is the symbol for Nanobiotix S.A. Stock and on which exchange is it traded?
The symbol for Nanobiotix S.A. is NBTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Nanobiotix S.A. Stock?
Nanobiotix S.A. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Nanobiotix S.A. Stock?
Nanobiotix S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Nanobiotix S.A. Stock.

What's the current price of Nanobiotix S.A. Stock?
As of the end of day on the Jul 03, 2024, the price of an Nanobiotix S.A. (NBTX) share was $5.40.

What is the 52-week high and low for Nanobiotix S.A. Stock?
The 52-week high for Nanobiotix S.A. Stock is $11.00 and the 52-week low is $4.14.

What is the market capitalization of Nanobiotix S.A. Stock?
As of the Jul 03, 2024, the market capitalization of Nanobiotix S.A. is 254.165M.
Click to get the best stock tips daily for free!

About Nanobiotix S.A.

Nanobiotix S.A. Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership ... NBTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT